USU Law
About Attorneys Articles Resources Contact
☎ (212) 755-0299
Food, Drug and Cosmetic Law Overview Regulatory Compliance Advising Importers and Exporters Advertising and Marketing Issues FDA Enforcement Defense FTC Enforcement Defense NAD Enforcement Compliance with FDA’s Premarket NDI Requirements Compliance with FDA’s GRAS Requirements Civil Litigation
AboutAttorneys Areas of Law Food, Drug and Cosmetic Law Overview Regulatory Compliance Advising Importers and Exporters Advertising and Marketing Issues FDA Enforcement Defense FTC Enforcement Defense NAD Enforcement Compliance with FDA’s Premarket NDI Requirements Compliance with FDA’s GRAS Requirements Civil Litigation ArticlesResourcesContact
USU Law
Ullman, Shapiro & Ullman, LLP
☎ (212) 755-0299
FDA: CBD Marketers Selling Unapproved Drugs
in the newsSCG CreativeApril 11, 2017
Facebook0 Twitter 0 Likes
Previous

Supplement Lawsuits Piling Up in Wake of NY AG Investigation

in the newsSCG CreativeApril 11, 2017
Next

More Supplement Manufacturers Complying with FDA GMP Regulations, But Room for Improvement

in the newsSCG CreativeApril 11, 2017

Schedule Appointment

Start Now

Ullman, Shapiro & Ullman, LLP  •  18 East 48th Street, Suite 1001  •  New York, NY 10017  •  212.755.0299 • Disclaimer